NAC-preHD
A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
Phase 2 study testing an investigational treatment in Huntington's disease.
RecruitingPhase 2DrugClinicalTrials.govTreatment trial
Recruiting in: Herston, Nedlands, Parkdale +2 more, Australia
Sponsor: Western Sydney Local Health District
Preparing a short plain-English summary.